Eugene

[email protected]

LATEST

Recipharm Appoints President, Development Services
By

By
Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization (CDMO), has appointed Bernard Pluta as president of development services to lead its new global development organization. Recipharm says the newly…

MedPharm To Expand Formulation-Development Lab Facility
By

By
MedPharm, a Guildford, England-headquartered provider of formulation and development services for topical and transdermal products, has invested £1 million ($1.4 million) to expand its formulation-development laboratories at its UK headquarters.…

ABEC Completes Cleanroom for Single-Use Biomanufacturing
By

By
ABEC, a Bethlehem, Pennsylvania-based engineering, equipment, and services provider, has completed its second cleanroom for single-use disposable container (DC) manufacturing. ABEC’s Bethlehem-based cleanroom has been fully operational since 2015, and…

LakePharma Launches Biomanufacturing Center
By

By
LakePharma, a Belmont, California-based biologics company specializing in antibody and protein engineering, cell-line development, and protein production, has launched the LakePharma MicroBiomanufacturing Center in Hopkinton, Massachusetts. The newly acquired 69,000-square-foot…

Lonza To Establish Cell- and Gene-Therapy Centers of Excellence
By

By
Lonza plans to establish centers of excellence for cell and gene therapy. Lonza’s Cell- and Gene-Therapy Centers of Excellence will include Lonza sites that are already functioning. The company says…

Former Celgene Executive’s Biotech Start-Up Celularity Raises $250 Million
By

By
Celularity, a Warren, New Jersey-headquartered biopharmaceutical company developing therapies from allogeneic cells and tissues derived from the postpartum placenta, has raised $250 million in funding from several investors, including Celgene,…

White House Issues Report on Policy Options for Drug Pricing and Innovation
By

By
The White House’s Council of Economic Advisers has released a report that outlines policy options to address drug pricing while promoting innovation. The report offers proposed changes to Medicare and…

Celgene Completes First Phase of CAR-T Mfg Facility
By

By
Celgene has completed the first phase a new immunotherapy manufacturing center for chimeric antigen receptor (CAR-T) therapies at its Summit West campus in New Jersey. Celgene says the 135,000-square-foot facility…

BMS, Nektar Therapeutics in Cancer Drug Pact Worth up to $3.63 Billion
By

By
Bristol-Myers Squibb (BMS) and Nektar Therapeutics, a biopharmaceutical company, have partnered to develop and commercialize Nektar’s lead immuno-oncology drug candidate in combination with BMS’ immuno-oncology drugs, Opdivo (nivolumab) and Opdivo…

FDA Issues Warning Letter to Bayer for Finished-Products Manufacturing Plant
By

By
The FDA has issued a Warning Letter to Bayer for good manufacturing practices (GMP) violations for finished pharmaceuticals based on an inspection of the company’s manufacturing facility in Leverkusen, Germany.…